Table 1 Baseline characteristics of the fondaparinux and enoxaparin groups
Characteristics | Fondaparinux (n = 430) | Enoxaparin (n = 463) | P |
|---|---|---|---|
Age (year) | 57.29 ± 9.39 | 58.16 ± 9.58 | 0.170 |
Male [n(%)] | 328 (76.3) | 363 (78.2) | 0.486 |
Weight (kg) | 72.04 ± 12.08 | 72.64 ± 13.05 | 0.487 |
Hypertension [n(%)] | 245 (57.2) | 276 (59.5) | 0.448 |
Diabetes [n(%)] | 98 (22.8) | 94 (20.3) | 0.357 |
Stroke [n(%)] | 14 (3.3) | 11 (2.4) | 0.423 |
Prior myocardial infarction [n(%)] | 50 (11.6) | 74 (15.9) | 0.060 |
Current smoker [n(%)] | 224 (52.1) | 246 (53.0) | 0.782 |
ACS [n(%)] | |||
Unstable angina | 216 (50.2) | 296 (68.3) | 0.658 |
Non-ST-elevation ACS | 52 (12.1) | 49 (10.6) | 0.477 |
ST-elevation MI | 162(37.7) | 119 (25.6) | <0.001 |
Target vessel position [n(%)] | |||
Left Main | 53 (12.3) | 66 (14.2) | 0.397 |
Left Anterior Descending | 278 (64.7) | 295 (63.6) | 0.771 |
Left Circumflex | 36 (8.4) | 39 (8.4) | 0.978 |
Right Coronary Artery | 46 (10.9) | 45 (9.7) | 0.629 |
PCI | |||
Average stent diameter (mm) | 3.03 ± 0.40 | 3.06 ± 0.40 | 0.181 |
Average length of stents (mm) | 27.17 ± 5.96 | 27.58 ± 5.89 | 0.293 |
Average number of stents | 1.85 ± 0.96 | 1.89 ± 1.02 | 0.627 |
Transradial artery invasive [n(%)] | 378 (87.9) | 408 (87.9) | 0.991 |
Tirofiban (d) | 1.84 ± 0.66 | 1.90 ± 0.62 | 0.495 |
Fondaparinux/enoxaparin (d) | 4.75 ± 1.81 | 4.57 ± 1.75 | 0.168 |
Laboratory examination | |||
APTT (s) | 33.39 ± 5.86 | 32.97 ± 5.57 | 0.271 |
Prothrombin time (s) | 12.97 ± 1.38 | 12.90 ± 1.07 | 0.381 |
HDL-C (mmol/L) | 1.19 ± 0.44 | 1.18 ± 0.58 | 0.639 |
Creatinine (mmol/L) | 87.50 ± 18.71 | 91.02 ± 15.02 | 0.116 |
PLT (×109/L) | 212.29 ± 56.09 | 212.50 ± 51.13 | 0.954 |